As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...
The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...
The integration of AI has the potential to enhance oncology clinical pathways, but there are important judgment calls that must be made before this technology can be fully implemented. The quest to ...
The current European legislation for in vitro diagnostic medical devices (IVD) (Regulation 2017/746 or the IVDR) has created challenges not only for IVD manufacturers but also for pharmaceutical ...
Edward "Ted" Arrowsmith, MD, MPH, medical director for pathways at OneOncology and managing partner at Tennessee Oncology, talks about challenges and changes in clinical pathways and the importance of ...
For many healthtech innovators the real adoption challenge is not always in proving the clinical value of their product. It is overcoming structural barriers that stand in their way. So, let’s explore ...
Despite advances in clinical cancer care, cancer survivors frequently report a range of persisting issues, unmet needs, and concerns that limit their ability to participate in life roles and reduce ...
As sponsor needs change strategic collaboration with CDMOs/CROs is becoming more important for execution and early input.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results